BG106748A - Method and compositions for treating pulmonary diseases - Google Patents

Method and compositions for treating pulmonary diseases

Info

Publication number
BG106748A
BG106748A BG106748A BG10674802A BG106748A BG 106748 A BG106748 A BG 106748A BG 106748 A BG106748 A BG 106748A BG 10674802 A BG10674802 A BG 10674802A BG 106748 A BG106748 A BG 106748A
Authority
BG
Bulgaria
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
BG106748A
Other languages
Bulgarian (bg)
Inventor
Peter GOODFELLOW
Richard Nieman
Theodore Torphy
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG106748A publication Critical patent/BG106748A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Изобретението се отнася до метод и състави за лечение на белодробни заболявания, например хронично обструктивно белодробно заболяване или астма, чрезприлагане на инхибитор на фосфодиестераза 4 в комбинация с противовъзпалителен кортикостероид.The invention relates to a method and compositions for treating pulmonary diseases, for example, chronic obstructive pulmonary disease or asthma, by administering a phosphodiesterase 4 inhibitor in combination with an anti-inflammatory corticosteroid.

BG106748A 1999-11-02 2002-05-29 Method and compositions for treating pulmonary diseases BG106748A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
BG106748A true BG106748A (en) 2003-02-28

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106748A BG106748A (en) 1999-11-02 2002-05-29 Method and compositions for treating pulmonary diseases

Country Status (29)

Country Link
EP (1) EP1225866A4 (en)
JP (1) JP2003513028A (en)
KR (1) KR20020057988A (en)
CN (1) CN1387404A (en)
AP (1) AP2002002496A0 (en)
AR (1) AR029189A1 (en)
AU (1) AU1357501A (en)
BG (1) BG106748A (en)
BR (1) BR0015270A (en)
CA (1) CA2388333A1 (en)
CO (1) CO5261512A1 (en)
CZ (1) CZ20021512A3 (en)
DZ (1) DZ3225A1 (en)
EA (1) EA200200518A1 (en)
EC (1) ECSP003747A (en)
HK (1) HK1049107A1 (en)
HU (1) HUP0203152A3 (en)
IL (1) IL149367A0 (en)
MA (1) MA26841A1 (en)
MX (1) MXPA02004350A (en)
NO (1) NO20022057L (en)
OA (1) OA12076A (en)
PE (1) PE20011005A1 (en)
PL (1) PL355261A1 (en)
SK (1) SK7592002A3 (en)
TR (1) TR200201211T2 (en)
TW (1) TWI242431B (en)
WO (1) WO2001032127A2 (en)
ZA (1) ZA200203435B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459757C (en) * 2001-09-19 2011-08-30 Altana Pharma Ag Combination
SK1862004A3 (en) * 2001-10-31 2004-08-03 Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (en) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2520577A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
BRPI0617673C1 (en) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd phosphodiesterase type iv inhibitor compositions
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710109T3 (en) * 1993-06-18 2005-01-03 Smithkline Beecham Corp Method of Identifying a PDE IV Inhibitor
DE4332041C2 (en) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Use of pentoxifylline in certain lung diseases
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
SE9801368D0 (en) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
EP1225866A2 (en) 2002-07-31
DZ3225A1 (en) 2001-05-10
BR0015270A (en) 2002-06-18
MXPA02004350A (en) 2002-11-07
WO2001032127A3 (en) 2001-12-06
IL149367A0 (en) 2002-11-10
EA200200518A1 (en) 2002-10-31
CO5261512A1 (en) 2003-03-31
PE20011005A1 (en) 2001-09-28
CZ20021512A3 (en) 2003-04-16
CN1387404A (en) 2002-12-25
AP2002002496A0 (en) 2002-06-30
PL355261A1 (en) 2004-04-05
HUP0203152A3 (en) 2004-06-28
HK1049107A1 (en) 2003-05-02
ZA200203435B (en) 2003-06-25
OA12076A (en) 2006-05-04
HUP0203152A2 (en) 2003-01-28
MA26841A1 (en) 2004-12-20
NO20022057L (en) 2002-06-27
ECSP003747A (en) 2002-05-23
AR029189A1 (en) 2003-06-18
SK7592002A3 (en) 2002-11-06
KR20020057988A (en) 2002-07-12
EP1225866A4 (en) 2004-04-21
TWI242431B (en) 2005-11-01
JP2003513028A (en) 2003-04-08
AU1357501A (en) 2001-05-14
CA2388333A1 (en) 2001-05-10
WO2001032127A2 (en) 2001-05-10
NO20022057D0 (en) 2002-04-30
TR200201211T2 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
TR200100500T2 (en) Therapies for the treatment of pulmonary diseases
EA200300293A1 (en) ANTI-INFLAMMATORY CONDENSED Pyrrolocarbazoles
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
MXPA04000793A (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma.
RS20050199A (en) Imidazolopyridines and methods of making and using the same
ATE486840T1 (en) MODIFIED FORMS OF PHARMACEUTICALLY ACTIVE AGENTS AND USES THEREOF
NO20060328L (en) Combination of mGluR2 antagonist and ACHE inhibitor for the treatment of acute and / or chronic neurological disorders
MA25809A1 (en) ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS
WO2004078144A3 (en) Diphenylethylene compounds and uses thereof
BR0212042A (en) Compound, pharmaceutical composition, method of treating or preventing disease, and use of a compound
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
SE9800836D0 (en) New Compounds
DE69920757D1 (en) IMMUNE SUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
WO2002076434A3 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
CR6824A (en) ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS
BG106748A (en) Method and compositions for treating pulmonary diseases
MXPA02010316A (en) Compositions and therapies for hyperlipidaemia associated disorders.
SE9900833D0 (en) Novel combination
DK0869965T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
MXPA03011702A (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
SE9900834D0 (en) Novel combination
BR0212607A (en) Replaced urea retinoid agonists ii